Jordan considers lowering European medicine prices

14 June 2010

The Jordan Food and Drug Administration (JFDA) is to consider lowering prices of medicine manufactured in Europe due to the drop in value of the euro against the Jordanian dinar, Jordan Times has reported. The JFDA studies exchange rates of the euro and revises drug prices every three months. According to JFDA figures, the kingdom's imports of European-manufactured medicine stood at JD110m ($154m) in 2009.

A MEED Subscription...

Subscribe or upgrade your current MEED.com package to support your strategic planning with the MENA region’s best source of business information. Proceed to our online shop below to find out more about the features in each package.

Get Notifications